Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Apr;257(1-2):3-16.
doi: 10.1007/s00232-024-00307-2. Epub 2024 Feb 14.

Potential Role of Nrf2, HER2, and ALDH in Cancer Stem Cells: A Narrative Review

Affiliations
Review

Potential Role of Nrf2, HER2, and ALDH in Cancer Stem Cells: A Narrative Review

Azadeh Fakhrioliaei et al. J Membr Biol. 2024 Apr.

Abstract

Cancer is one of the main causes of death among humans, second only to cardiovascular diseases. In recent years, numerous studies have been conducted on the pathophysiology of cancer, and it has been established that this disease is developed by a group of stem cells known as cancer stem cells (CSCs). Thus, cancer is considered a stem cell disease; however, there is no comprehensive consensus about the characteristics of these cells. Several different signaling pathways including Notch, Hedgehog, transforming growth factor-β (TGF-β), and WNT/β-catenin pathways cause the self-renewal of CSCs. CSCs change their metabolic pathways in order to access easy energy. Therefore, one of the key objectives of researchers in cancer treatment is to destroy CSCs. Nuclear factor erythroid 2-related factor 2 (Nrf2) plays an essential role in the protection of CSCs from reactive oxygen species (ROS) and chemotherapeutic agents by regulating antioxidants and detoxification enzymes. Human epidermal growth factor receptor 2 (HER2) is a member of the tyrosine kinase receptor family, which contributes to the protection of cancer cells against treatment and implicated in the invasion, epithelial-mesenchymal transition (EMT), and tumorigenesis. Aldehyde dehydrogenases (ALDHs) are highly active in CSCs and protect the cells against damage caused by active aldehydes through the regulation of aldehyde metabolism. On the other hand, ALDHs promote the formation and maintenance of tumor cells and lead to drug resistance in tumors through the activation of various signaling pathways, such as the ALDH1A1/HIF-1α/VEGF axis and Wnt/β-catenin, as well as changing the intracellular pH value. Given the growing body of information in this field, in the present narrative review, we attempted to shed light on the function of Nrf2, HER2, and ALDH in CSCs.

Keywords: Aldehyde dehydrogenases; Cancer stem cells; Chemotherapy; HER2; Nuclear factor erythroid 2-related factor 2.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Abgarmi ZM, Lotfi AS, Abroun S, Soleimani M, Ganji SM (2018) Inhibition of Erbb2 by trastuzumab induces oxidative stress markers in HER2 positive breast cancer cell lines. J Res Med Dental Sci 6(3):158–165
    1. Ayob AZ, Ramasamy TS (2018) Cancer stem cells as key drivers of tumour progression. J Biomed Sci 25(1):20. https://doi.org/10.1186/s12929-018-0426-4 - DOI - PubMed - PMC
    1. Batlle E, Clevers H (2017) Cancer stem cells revisited. Nat Med 23(10):1124 - PubMed - DOI
    1. Bayik D, Lathia JD (2021) Cancer stem cell–immune cell crosstalk in tumour progression. Nat Rev Cancer 21(8):526–536 - PubMed - PMC - DOI
    1. Bomken S, Fišer K, Heidenreich O, Vormoor J (2010) Understanding the cancer stem cell. Br J Cancer 103(4):439–445 - PubMed - PMC - DOI

MeSH terms

LinkOut - more resources